HCF Laudabilis Indias’ Orsus in Developing Stem Cell Research Technology
Humanus Cloning Crepidoinis (HCF) said India’s repens habenae orsus ut porro development of stem cell research es “ laudabilis quod pondero proventus worldwide fossa ut ostendo broadening habenae sollicitudo quod suscipio pro stem cell research,” said HCF orator David Madrigal.
“nos have developed utriusque brevis quod porro-term ars pro research quod development in stem cell (technology). habenae, in tunc duos mensis, mos solvo Rs2 crore ( super US460,000$) versus firmamentum stem cell research in terra” India’s Iugum Minister pro Scientia quod Technology Kapil Sibal told Chennai Novus.
Sibal said in brevis-term, habenae would succurro fulcio research activities in mononuclear cells ut they operor non causa immune infitialis. Is said habenae would quoque involve res defero facio available beneficium of stem cell technology ut vulgaris vir quod scisco lemma insequor standardized Bonus Fabrica Processus (GMP) ut subsequens ut uber es acceptable in extrarius venalicium.
David Madrigal, HCF orator, said India has iunctus an elite album of terra ut have innotesco ingens potential of cloning quod stem cell research in curatio morbus quod improvidus species of vita.
radix PR Solvo per David Madrigal of HCF
contactus David Madrigal
Orator, Humanus Cloning Crepidoinis
humancloning . david @ gmail . com
www.humancloning.org
































